1. Home
  2. SKE vs MMED Comparison

SKE vs MMED Comparison

Compare SKE & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skeena Resources Limited

SKE

Skeena Resources Limited

HOLD

Current Price

$31.16

Market Cap

3.8B

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$11.48

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SKE
MMED
Founded
1979
1983
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.1B
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
SKE
MMED
Price
$31.16
$11.48
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$22.56
AVG Volume (30 Days)
555.7K
694.7K
Earning Date
05-12-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.99
Revenue Next Year
$37,573.35
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.40
$11.45
52 Week High
$38.77
$17.86

Technical Indicators

Market Signals
Indicator
SKE
MMED
Relative Strength Index (RSI) 51.31 31.12
Support Level $30.44 N/A
Resistance Level $34.96 $15.80
Average True Range (ATR) 1.24 0.69
MACD -0.06 -0.09
Stochastic Oscillator 43.46 3.93

Price Performance

Historical Comparison
SKE
MMED

About SKE Skeena Resources Limited

Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

Share on Social Networks: